Anpario (LON:ANP) Sets New 1-Year High – Should You Buy?

Shares of Anpario plc (LON:ANP) hit a new 52-week high during trading on Monday . The stock traded as high as GBX 398.50 ($4.99) and last traded at GBX 389 ($4.87), with a volume of 46046 shares trading hands. The stock had previously closed at GBX 385 ($4.82).

Analysts Set New Price Targets

A number of analysts have weighed in on ANP shares. Shore Capital restated a “house stock” rating on shares of Anpario in a research note on Wednesday, September 11th. Canaccord Genuity Group raised their price target on shares of Anpario from GBX 340 ($4.25) to GBX 370 ($4.63) and gave the company a “buy” rating in a research report on Wednesday, September 18th.

Anpario Stock Performance

The company has a quick ratio of 5.16, a current ratio of 6.15 and a debt-to-equity ratio of 0.21. The stock has a market capitalization of £66.20 million, a P/E ratio of 2,175.00 and a beta of 0.58. The business has a fifty day moving average price of GBX 345.80 and a 200-day moving average price of GBX 315.77.

Insiders Place Their Bets

In other news, insider Karen Prior sold 14,000 shares of the stock in a transaction on Friday, December 13th. The stock was sold at an average price of GBX 380 ($4.76), for a total transaction of £53,200 ($66,574.90). 30.51% of the stock is owned by insiders.

About Anpario

Anpario plc, together with its subsidiaries, engages in the production and distribution of natural feed additives for animal health, hygiene, and nutrition. Its health and performance category offers various products that support and maintain animal gut health, such as phytogenic and acid based eubiotics, and omega fatty acids under the Orego-Stim, Optomega, pHorce, Salkil, and Genex brands; feed quality category provides products, such as enzymes, antioxidants, pellet binders, mould inhibitors, and acid based eubiotics under the pHorce, Feedzyme, Salgard, Oxigard, Moldgard, and Mastercube brands.